Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02959034 · ClinicalTrials.gov registry record
Pediatric Metabolism and Microbiome Repository
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 486
- Enrollment target
NCT02959034: Completed study, sponsored by Duke University.
NCT02959034 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 486 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02959034 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 486 participants
- Enrollment target
Study Summary
The aim of this project is to establish a bio-repository of diverse specimen types to provide investigators access to specimens in order to further research related to metabolism and the microbiome in the pediatric population.
Primary Outcome
measures of metabolomics using a sample biorepository
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 486 participants |
| Start Date | 2016-09 |
| Est. Completion | 2021-01-13 |
What the finished NCT02959034 record still lists
NCT02959034 is an observational study that tracks outcomes without assigning an intervention. The registered 486 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02959034 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02959034 about?
NCT02959034 is a clinical study titled "Pediatric Metabolism and Microbiome Repository". The aim of this project is to establish a bio-repository of diverse specimen types to provide investigators access to specimens in order to further research related to metabolism and the microbiome in the pediatric population.
What is the current status of trial NCT02959034?
This trial is currently completed. The enrollment target is 486 participants. The study started on 2016-09. Estimated completion is 2021-01-13.
Who is sponsoring clinical trial NCT02959034?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06420531 · 486 participants · NA
Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial
- NCT07097142 · 486 participants · Phase 3
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- NCT06948435 · 487 participants · Phase 3
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
- NCT06952530 · 487 participants · Phase 3
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia